Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.036 AUD | -8.86% | -10.00% | -51.35% |
May. 08 | Radiopharm Theranostics to be Featured in Healthcare Events Hosted by B. Riley Securities | MT |
Feb. 29 | Radiopharm Theranostics Doses First Patient in Pancreatic Cancer Imaging Study | MT |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Radiopharmaceutical Products
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 21-09-12 | |
Antje Wegener
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gitasha Chand
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Sherin Al-Safadi
CTO | Chief Tech/Sci/R&D Officer | - | 23-07-23 |
David Mozley
CTO | Chief Tech/Sci/R&D Officer | - | - |
Scot Harper
CTO | Chief Tech/Sci/R&D Officer | 67 | 21-11-30 |
Vittorio Puppo
COO | Chief Operating Officer | - | 22-05-31 |
Levente Meszaros
PRN | Corporate Officer/Principal | - | 21-12-31 |
Nathan Jong
SEC | Corporate Secretary | - | - |
Thomas Tulip
PRN | Corporate Officer/Principal | 71 | 21-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Hopper
CHM | Chairman | 68 | 21-02-10 |
Leila Alland
BRD | Director/Board Member | 61 | 22-06-05 |
Chief Executive Officer | - | 21-09-12 | |
Ian Turner
BRD | Director/Board Member | - | - |
Hester Larkin
BRD | Director/Board Member | - | 22-02-02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 371,639,096 | 274,806,210 ( 73.94 %) | 0 | 73.94 % |
Company contact information
Sector
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-51.35% | 10.87M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- RAD Stock
- Company Radiopharm Theranostics Limited